C. Katona

G. Livingston, C. Katona, C. Cooper, 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Drug treatment of older people with affective disorders in the community: lessons from an attempted clinical trial

G. Livingston, C. Katona, T. Stevens, 1999, International Journal of Geriatric Psychiatry.

Quality of life in older people

G. Livingston, C. Katona, R. Rosser, 1998 .

Sulpiride-induced tardive dyskinesia in a person with Gilles de la Tourette syndrome

C. Katona, M. Robertson, T. Barnes, 1993, Journal of psychopharmacology.

Optimizing treatment for the elderly depressive: new antidepressants in the elderly

C. Katona, 1993, Journal of psychopharmacology.

Platelet high affinity adrenoceptor binding sites labelled with the agonist [3H]UK-14,304, in depressed patients and matched controls.

C. Katona, E. Paykel, A. Hale, 1986, European journal of pharmacology.

Depression in carers of elderly people living at home

G. Livingston, C. Katona, 1996, BMJ.

Slicing the health cake: The Islington Study

Martin Knapp, Gill Livingston, Tanya Nelson, 2002 .

New antidepressants for older people: a critical review of the evidence base.

C. Katona, 2008, L'Encephale.

Study of the use of anti-depressants for depression in dementia : the HTA-SADD Trial-a multicentre randomised double-blind , placebo-controlled trial of the clinical effectiveness of sertraline and mirtazapine

Alan J. Thomas, J. Lindesay, G. Livingston, 2011 .

Platelet radioligand binding and neuroendocrine challenge tests in depression.

C. Katona, E. Paykel, A. Hale, 1986, Ciba Foundation symposium.

Managing depression and anxiety in the elderly patient

C. Katona, 2000, European Neuropsychopharmacology.

Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment

C. Katona, R. Horton, M. Crompton, 1994, Brain Research.

NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides

C. Katona, J. Maloteaux, R. Horton, 1993, Brain Research.

The dexamethasone suppression test in geriatric psychiatry

C. Katona, 1988 .

The Dexamethasone Suppression Test and Prediction of Outcome in Patients Receiving ECT

C. Katona, J. Hyde, C. Aldridge, 1987, British Journal of Psychiatry.

Prediction of ect response

C. Katona, C. Aldridge, C. Katona, 1984, Neuropharmacology.

The aetiology of late life depression

C. Katona, N. Graham, R. Baldwin, 2002 .

Corticotropin-releasing factor immunoreactivity in post-mortem brain from depressed suicides

I. Ferrier, C. Katona, B. Charlton, 1988, Journal of psychopharmacology.

Antidepressants for older people: what can we learn from the current evidence base?

C. Katona, D. Bindman, Cara P Katona, 2014, Maturitas.

The Hamilton Rating Scale for Depression

C. Katona, N. Graham, R. Baldwin, 2002 .

Brain 5-hydroxytryptamine uptake sites labeled with [3H]paroxetine in antidepressant drug-treated depressed suicide victims and controls.

C. Katona, R. Horton, M. Crompton, 1997, Journal of psychiatry & neuroscience : JPN.

A UK national survey of the management of depression by geriatricians and old age psychiatrists

M. Orrell, C. Katona, E. Collins, 1995 .

Brain GABAB binding sites in depressed suicide victims

C. Katona, S. Cheetham, R. Horton, 1988, Psychiatry Research.

Managing depression in older people

C. Katona, 1996, European Psychiatry.

Brain 5-HT Uptake Sites, Labelled with [3H]Paroxetine, in Depressed Suicides

C. Katona, S. Cheetham, R. Horton, 1991 .

Biological treatment of unipolar depressive disorders in the general practitioner's medical care: Guidelines of the World Federation of Societies of Biological Psychiatry (WFSBP)

Gheorghe, D. Kupfer, H. Möller, 2008 .

Drug Treatment in Old Age Psychiatry

G. Livingston, C. Katona, 2002 .

Accessibility of health and social services to immigrant elders: the Islington Study.

G. Livingston, C. Katona, G. Leavey, 2002, The British journal of psychiatry : the journal of mental science.

Mental health of migrant elders – the Islington study

G. Livingston, C. Katona, G. Leavey, 2001, British Journal of Psychiatry.

Psychiatric admissions and social deprivation: is the Jarman underprivileged area score relevant?

C. Katona, A. Cotgrove, G. Bell, 1992, Journal of epidemiology and community health.

Antidepressant effects of electroconvulsive therapy.

C. Katona, C. Aldridge, 1983, British medical journal.

There is no evidence supporting population screening for dementia: Reporting on a systematic review of costs and benefits

C. Katona, C. Brayne, G. Rait, 2013, Alzheimer's & Dementia.

Lithium augmentation in refractory depression.

C. Katona, 1988, Psychiatric developments.

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.

M. Orrell, J. Lindesay, J. O'Brien, 2013, Health technology assessment.

[3H]Yohimbine binding to platelet α2-adrenoceptors in depression

C. Katona, E. Paykel, A. Hale, 1989 .

3H-imipramine binding to freshly prepared platelet membranes in depression

C. Katona, E. Paykel, A. Hale, 1989, Psychiatry Research.

Guidelines for treating depressive illness with antidepressants

C. Katona, B. Leonard, P. Bebbington, 1993, Journal of psychopharmacology.

Medication errors in older people with mental health problems: a review

C. Katona, B. Franklin, I. Maidment, 2008, International Journal of Geriatric Psychiatry.

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

A Malizia, P. Cowen, A. Malizia, 2015, Journal of psychopharmacology.

Brain 5-HT2 receptor binding sites in depressed suicide victims

C. Katona, S. Cheetham, R. Horton, 1988, Brain Research.

Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study

Cornelius Katona, Simon Coulton, Carol Brayne, 2011, Journal of the American Geriatrics Society.

Antipsychotics and cognitive decline in Alzheimer’s disease: the LASER-Alzheimer’s disease longitudinal study

G. Livingston, C. Katona, C. Cooper, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Drug repositioning for Alzheimer's disease

Paul Edison, Anne Corbett, Cornelius Katona, 2012, Nature Reviews Drug Discovery.

Long-term outcome of severe puerperal psychiatric illness: a 23 year follow-up study

C. Katona, E. Paykel, R. Abbott, 2000, Psychological Medicine.

Coping strategies, anxiety and depression in caregivers of people with Alzheimer's disease

Martin Orrell, Gill Livingston, Cornelius Katona, 2008, International journal of geriatric psychiatry.

Systematic review of the effectiveness of pharmacologic interventions to improve quality of life and well-being in people with dementia.

C. Lyketsos, P. Rabins, G. Livingston, 2013, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Quality of life in dementia: care recipient and caregiver perceptions of quality of life in dementia: the LASER‐AD study

M. Orrell, G. Livingston, C. Katona, 2007, International journal of geriatric psychiatry.

Successful ageing in adversity: the LASER–AD longitudinal study

G. Livingston, C. Katona, C. Cooper, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Treatment of patients who lack capacity

G. Livingston, C. Katona, A. Hassiotis, 1998 .

Screening for elder abuse in dementia in the LASER‐AD study: prevalence, correlates and validation of instruments

G. Livingston, C. Katona, C. Cooper, 2008, International journal of geriatric psychiatry.

Coping strategies and anxiety in caregivers of people with Alzheimer's disease: the LASER-AD study.

Martin Orrell, Gill Livingston, Cornelius Katona, 2006, Journal of affective disorders.

The assessment and management of behavioural manifestations of dementia: a review and results of a controlled trial.

G. Livingston, C. Katona, A. Hinchliffe, 1997, International journal of psychiatry in clinical practice.

A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.

C. Katona, J. Nelson, K. Delucchi, 2014, Journal of affective disorders.

Attitudes and preferences towards screening for dementia: a systematic review

C. Katona, C. Brayne, G. Rait, 2014, The Lancet.

Brain α-adrenoceptors in depressed suicides

C. Katona, R. Horton, M. Crompton, 1997, Brain Research.

Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides

C. Katona, S. Cheetham, R. Horton, 1990, Brain Research.

Carry on shrinking: career intentions and attitudes to psychiatry of prospective medical students

G. Livingston, C. Katona, Rachel Maidment, 2003 .

Predictors of response to amine-specific antidepressants.

M. Abou-Saleh, C. Katona, M. Robertson, 1995, Journal of affective disorders.

Safety and Tolerability of Duloxetine at 60 mg Once Daily in Elderly Patients With Major Depressive Disorder

C. Katona, J. Raskin, D. Desaiah, 2008, Journal of clinical psychopharmacology.

Anxiety and depression in family caregivers of people with Alzheimer disease: the LASER-AD study.

Gill Livingston, Cornelius Katona, G. Livingston, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Characteristics and health status change over 6 months in people with moderately severe to severe Alzheimer's disease in the U.K.

G. Livingston, C. Katona, C. François, 2006, International Psychogeriatrics.

The attractions of medicine: the generic motivations of medical school applicants in relation to demography, personality and achievement

I. McManus, G. Livingston, C. Katona, 2006, BMC medical education.

Delusions and hallucinations in old age

C. Katona, R. Lévy, 1992 .

Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls

C. Katona, S. Cheetham, R. Horton, 1997, Brain Research.

Psychiatry at a Glance

C. Katona, M. Robertson, 1995 .

Dopamine uptake sites, labelled with [3H]GBR12935, in brain samples from depressed suicides and controls

C. Katona, S. Cheetham, R. Horton, 1997, European Neuropsychopharmacology.

Relationship of exercise and other risk factors to depression of Alzheimer's disease: the LASER‐AD study

G. Livingston, C. Katona, C. Regan, 2005, International journal of geriatric psychiatry.

Puerperal Mental Illness: Comparisons with Non-Puerperal Controls

C. Katona, 1982, British Journal of Psychiatry.

CHAPTER 57 – Functional Psychiatric Illness in Old Age

G. Livingston, C. Katona, C. Cooper, 2008 .

Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial

S. Reeves, G. Livingston, C. Katona, 2018, The lancet. Psychiatry.

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial

Alan J. Thomas, M. Orrell, J. Lindesay, 2011, The Lancet.

Escitalopram prevents relapse in older patients with major depressive disorder.

C. Katona, E. Weiller, P. Gorwood, 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial

G. Livingston, M. Boustani, C. Katona, 2012, PloS one.

Relationship of vascular risk to the progression of Alzheimer disease

G. Livingston, C. Katona, C. Regan, 2006, Neurology.

Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia

Naaheed Mukadam, Gill Livingston, Henry Brodaty, 2012, International Psychogeriatrics.

Mental health care for the elderly in low-income countries: a health systems approach.

G. Livingston, C. Katona, M. Prince, 2007, World psychiatry : official journal of the World Psychiatric Association.

Validation and normative data of health status measures in older people: the Islington study

G. Livingston, C. Katona, A. Bowling, 2001, International journal of geriatric psychiatry.

Validity and Reliability of the Brief COPE in Carers of People With Dementia: The LASER-AD Study

G. Livingston, C. Katona, C. Cooper, 2008, The Journal of nervous and mental disease.

New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder

C. Katona, Cara P Katona, 2014, Neuropsychiatric disease and treatment.

The relationship between medical school of training, age, gender and success in the MRCPsych examinations

W. Leung, C. Katona, S. Tyrer, 2002 .

Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)

J. Lindesay, T. Johnson, I. McKeith, 2016, International journal of geriatric psychiatry.

Cost effectiveness of memantine in Alzheimer's disease in the UK

G. Livingston, C. Katona, B. Rive, 2010, Journal of medical economics.

Changes to the MRCPsych examinations

C. Katona, S. Tyrer, Julie Smalls, 2000 .

Donepezil for the treatment of agitation in Alzheimer's disease.

Martin Knapp, Cornelius Katona, James Lindesay, 2007, The New England journal of medicine.

Concordance therapy: an intervention to help older people take antidepressants.

G. Livingston, C. Katona, N. Higgins, 2004, Journal of affective disorders.

‘Just keep taking the tablets’: adherence to antidepressant treatment in older people in primary care

Gill Livingston, Cornelius Katona, G. Livingston, 2002, International journal of geriatric psychiatry.

Reduced dopamine turnover in the basal ganglia of depressed suicides

C. Katona, S. Cheetham, R. Horton, 1997, Brain Research.

Safety and tolerability of duloxetine in elderly patients with major depressive disorder: a pooled analysis of two placebo-controlled studies

C. Katona, J. Greist, P. Liu, 2013, International clinical psychopharmacology.

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial.

C. Katona, M. Versiani, H. Woelk, 1999, Journal of affective disorders.

Symmetrical hemispheric distribution of 3H-Paroxetine binding sites in postmortem human brain from controls and suicides

C. Katona, S. Cheetham, R. Horton, 1990, Biological Psychiatry.

The potential of case management for people with dementia: a commentary

L. Robinson, C. Chew‐Graham, S. Iliffe, 2012, International journal of geriatric psychiatry.

Slicing the health service cake: the Islington study.

G. Livingston, C. Katona, M. Knapp, 2002, Age and ageing.

Predicting time to full-time care in AD: a new model

G. Livingston, C. Katona, B. Rive, 2010, Journal of medical economics.

The relationships between neuropsychiatric symptoms, cognitive deficit and prescription of psychotropics in Alzheimerís Disease: The LASER-AD study Korelacje pomiŒdzy objawami neuropsychiatrycznymi, deficytami poznawczymi, a przepisaniem lekÛw psychotropicznych u chorych z chorob" Alzheimera. Projek

G. Livingston, C. Katona, G. Train, 2004 .

The relationships between neuropsychiatric symptoms , cognitive deficit and prescription of psychotropics in Alzheimer s Disease : The LASER-AD study

G. Livingston, C. Katona, G. Train, 2022 .

Neuropsychological performance in Lewy body dementia and Alzheimer's disease

Z Walker, C. Katona, Z. Walker, 1997, British Journal of Psychiatry.

Brain 5-HT1 binding sites in depressed suicides

C. Katona, S. Cheetham, R. Horton, 2005, Psychopharmacology.

Brain β-adrenoceptor binding sites in antidepressant-free depressed suicide victims

C. Katona, S. Cheetham, R. Horton, 1990, Brain Research.

Cost of community care for older people

G. Livingston, C. Katona, M. Manela, 1997, British Journal of Psychiatry.

A survey of academic provision for old age psychiatry in the UK and Ireland

J. Lindesay, C. Katona, J. Warner, 2002 .

Survey of undergraduate teaching of old age psychiatry in the United Kingdom

C. Katona, Gabrielle M. Faire, 1993 .

How do general practitioners select antidepressants for depressed elderly people?

M. Orrell, C. Katona, E. Collins, 2000, International journal of geriatric psychiatry.

Attachment style and anxiety in carers of people with Alzheimer's disease: results from the LASER-AD study

G. Livingston, C. Katona, C. Cooper, 2008, International Psychogeriatrics.

Shortage specialties: changes in career intentions from medical student to newly qualified doctor

G. Livingston, C. Katona, L. Noble, 2004, Medical teacher.

The AdHOC Study of older adults' adherence to medication in 11 countries.

G. Livingston, M. Schroll, C. Katona, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Placebo‐controlled trial of lithium augmentation of fluoxetine and lofepramine

M. Abou-Saleh, C. Katona, M. Robertson, 1995, British Journal of Psychiatry.

Altered brain protein kinase C in depression: a post-mortem study

C. Katona, R. Horton, M. A. Coull, 2000, European Neuropsychopharmacology.

5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls.

C. Katona, S. Cheetham, R. Horton, 1997, Journal of affective disorders.

Suicide rates in Hungary correlate negatively with reported rates of depression.

C. Katona, Z. Rihmer, J. Barsi, 1990, Journal of affective disorders.

Minor Depression in the Aged

C. Katona, C. Tannock, 1995 .

Systematic review of the effect of psychological interventions on family caregivers of people with dementia.

C. Lyketsos, G. Livingston, C. Katona, 2007, Journal of affective disorders.

Reducing stigma and discrimination against older people with mental disorders: a technical consensus statement

J. Lindesay, J. Copeland, C. Katona, 2003, International journal of geriatric psychiatry.

Growth hormone and physiological responses to clonidine in depression

C. Katona, E. Paykel, D. Healy, 1993, Psychological Medicine.

Pain symptoms in depression: definition and clinical significance.

Elizabeth Wager, Cornelius Katona, Christopher Dowrick, 2005, Clinical medicine.

International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia

G. Livingston, C. Katona, H. Brodaty, 2007, International Psychogeriatrics.

A systematic review of treatments for refractory depression in older people.

P. Rabins, G. Livingston, C. Katona, 2011, The American journal of psychiatry.

The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study.

G. Livingston, M. Boustani, C. Katona, 2011, Age and ageing.

Medication management—the missing link in dementia interventions

M. Boustani, C. Katona, I. Maidment, 2012, International journal of geriatric psychiatry.

Differences in symptomatology and diagnostic profile in younger and elderly depressed inpatients.

C. Katona, P. Bech, P. Kragh‐Sørensen, 2001, Journal of affective disorders.

Refugees Who Have Experienced Extreme Cruelty: A Qualitative Study of Mental Health and Wellbeing after Being Granted Leave to Remain in the UK

C. Katona, N. Morant, Lauren Rowley, 2020, Journal of Immigrant & Refugee Studies.

The aetiology of depression in old age

C. Katona, 1993 .

Monetary costs of agitation in older adults with Alzheimer's disease in the UK: prospective cohort study

G. Livingston, G. Baio, C. Katona, 2015, BMJ Open.

A double‐blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia

C. Katona, B. Hunter, J. Bray, 1998 .

Pharmacotherapy of Affective Disorders

S. Shergill, C. Katona, 2001 .

5-HT1D and 5-HT1E/1F binding sites in depressed suicides: increased 5-HT1D binding in globus pallidus but not cortex

C. Katona, R. Horton, M. Crompton, 1997, Molecular Psychiatry.

Change in attitudes to psychiatry and intention to pursue psychiatry as a career in newly qualified doctors: a follow-up of two cohorts of medical students

G. Livingston, C. Katona, L. Noble, 2004, Medical teacher.

Perspectives of carers on medication management in dementia: lessons from collaboratively developing a research proposal

C. Katona, H. Pinnock, I. Maidment, 2014, BMC Research Notes.

Contribution of medical students to admission interviews

P. Rees, C. Katona, T. Koç, 2008, Medical education.

Successful aging in health adversity: results from the National Psychiatric Morbidity Survey

G. Livingston, C. Katona, P. Bebbington, 2009, International Psychogeriatrics.

The natural history of depression and the anxiety disorders in older people: the Islington community study.

G. Livingston, C. Katona, M. Manela, 1997, Journal of affective disorders.

Do anticholinergic drugs contribute to functional and cognitive decline

M. Boustani, C. Katona, I. Maidment, 2012 .

Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial

Alan J. Thomas, J. Lindesay, J. O'Brien, 2013, British Journal of Psychiatry.

Psychiatric morbidity in elderly attenders at an accident and emergency department

C. Katona, P. D'Ath, C. Katona, 1995 .

Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine

M. Abou-Saleh, C. Katona, M. Robertson, 1994, Psychopharmacology.

Audit of oral examinations in psychiatry.

C. Katona, R. Allison, 1992, Medical Teacher.

Drug treatment for Alzheimer's disease: the way forward

G. Livingston, C. Katona, I. Maidment, 2006, International journal of geriatric psychiatry.

Memantine combined with an acetyl cholinesterase inhibitor – hope for the future?

M. Boustani, C. Katona, I. Maidment, 2006, Neuropsychiatric disease and treatment.

Effective and acceptable treatment for depression.

C. Katona, M. Robertson, 1993, British medical journal.

Affective disorders in old age: detection and clinical features

C. Katona, 2018 .

Pain and depression in older people: comorbidity and patterns of help seeking.

R. de Graaf, C. Katona, J. Haro, 2009, Journal of affective disorders.

Post-mortem studies of brain phosphatidylinositol hydrolysis in depression and the effect of antidepressant treatment.

C. Katona, R. Horton, M. A. Coull, 2000, The international journal of neuropsychopharmacology.

Are old-old patients with major depression more likely to relapse than young-old patients during continuation treatment with escitalopram?

C. Lyketsos, C. Katona, E. Weiller, 2011, BMC geriatrics.

Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims

C. Katona, S. Cheetham, R. Horton, 1988, Brain Research.

Benzodiazepine binding sites in amygdala and hippocampus of depressed suicide victims.

G. M. Stocks, C. Katona, S. Cheetham, 1990, Journal of affective disorders.

What causes problems in Alzheimer's disease: attributions by caregivers. A qualitative study

G. Livingston, C. Katona, J. Paton, 2004, International journal of geriatric psychiatry.

A dependency model for patients with Alzheimer's disease: its validation and relationship to the costs of care – the LASER-AD Study

G. Livingston, C. Katona, B. Rive, 2004, Current medical research and opinion.

Differentiation between Alzheimer's disease and multi‐infarct dementia: Spect vs MR imaging

C. Katona, P. Ell, D. Costa, 1995 .

Association between pain and depression among older adults in Europe: results from the Aged in Home Care (AdHOC) project: a cross-sectional study.

C. Katona, G. Onder, H. Finne-Soveri, 2005, The Journal of clinical psychiatry.

The Mini‐SIB: a short scale for measuring cognitive function in severe dementia

M. Orrell, C. Katona, P. Simmons, 2005, International journal of geriatric psychiatry.

Screening for alcohol misuse in older people

G. Livingston, C. Katona, S. Shergill, 1997, International journal of geriatric psychiatry.

Prediction of survival in Alzheimer's disease—The LASER‐AD longitudinal study

Robert Blizard, Gill Livingston, Cornelius Katona, 2009, International journal of geriatric psychiatry.

In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies

C. Katona, P. Ince, D. Costa, 1999, The Lancet.

Dementia with Lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon mission tomography

C. Katona, D. Costa, Z. Walker, 1997, European Journal of Nuclear Medicine.

Neuropsychological and imaging differences in dementia with Lewy bodies and Alzheimer's disease

C. Katona, Z. Walker, R. Allen, 1997, British Journal of Psychiatry.

Persistence of and changes in neuropsychiatric symptoms in Alzheimer disease over 6 months: the LASER-AD study.

S. Ryu, G. Livingston, C. Katona, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

A systematic review of costs and benefits of population screening for dementia

C. Katona, C. Brayne, G. Rait, 2013, The Lancet.

Susceptibility to drug-induced hypotension in post-partum psychosis.

C. Katona, T. Barnes, 1986, International clinical psychopharmacology.

Caregivers’ experience of risk in dementia: The LASER-AD Study

G. Livingston, C. Katona, C. Cooper, 2006, Aging & mental health.

Does diagnosis determine delivery? The Islington study of older people's needs and health care costs

G. Livingston, C. Katona, M. Knapp, 2004, Psychological Medicine.

Outcome in refractory depression.

S. Shergill, C. Katona, M. Robertson, 1999, Journal of affective disorders.

Pharmacological choices after one antidepressant fails: a survey of UK psychiatrists.

S. Shergill, C. Katona, 1997, Journal of affective disorders.

Somatic symptoms and depression: diagnostic confusion and clinical neglect.

C. Dowrick, C. Katona, R. Peveler, 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.

Current Anticholinergic Medication Use And Cognitive Impairment In The Older Population: The Medical Research Council Cognitive Function and Ageing Study

G. Livingston, C. Katona, C. Brayne, 2009, Alzheimer's & Dementia.

Comorbidity with depression in older people: the Islington Study

G. Livingston, C. Katona, M. Manela, 1997 .

Rationalizing antidepressants for elderly people

C. Katona, 1995, International clinical psychopharmacology.

Refractory depression: A review with particular reference to the use of lithium augmentation

C. Katona, 1995, European Neuropsychopharmacology.

Patients' attitudes of dementia screening across the Atlantic

Michael D. Justiss, M. Boustani, C. Katona, 2009, International journal of geriatric psychiatry.

The measurement of depression in old age

C. Katona, 1993 .

The symptomatology of depression in the elderly

M. Orrell, G. Livingston, C. Katona, 1997, International clinical psychopharmacology.

Brainβ-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatment

C. Katona, S. Cheetham, R. Horton, 2005, Psychopharmacology.

Optimising primary care for people with dementia.

C. Chew‐Graham, C. Katona, E. Moniz-Cook, 2013, Mental health in family medicine.

Analysing UK clinicians' understanding of cognitive symptoms in major depression: A survey of primary care physicians and psychiatrists.

A. Young, G. Goodwin, C. Katona, 2017, Journal of affective disorders.

A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness

M. Abou-Saleh, C. Katona, M. Robertson, 1994, Journal of psychopharmacology.

Partners in Care

C. Katona, P. Katona, 2004 .

Psychotropics and drug interactions in the elderly patient

C. Katona, 2001, International journal of geriatric psychiatry.

Depression and Physical Illness: A Practical Guide

C. Katona, M. Robertson, M. Robertson, 1997 .

Minor depression in the aged. Concepts, prevalence and optimal management.

C. Katona, C. Tannock, 1995, Drugs & Aging.

longitudinal study disease : the LASER-Alzheimer ’ s disease Antipsychotics and cognitive decline in Alzheimer ’ s

G. Livingston, C. Katona, C. Cooper, 2006 .

Guidelines on Depression in Older People: Practising the Evidence BY ROBERT C BALDWIN, EDMOND CHIU, CORNELIUS KATONA AND NORI GRAHAM London: Martin Dunitz, 2002, U.K. 19.95. Paperback, pp. 162pp. ISBN 184 184 1269

C. Katona, N. Graham, R. Baldwin, 2002, International Psychogeriatrics.

Screening, detection and management of depression in elderly primary care attenders. I: The acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions.

C. Katona, P. D'Ath, P. Katona, 1994, Family practice.

The Future of CPD

Cornelius Katona, C. Katona, Gethin Morgan, 1999 .

Capgras Syndrome in Association with Lithium Toxicity

C. Katona, Bala Canagasabey, 1991, British Journal of Psychiatry.

Predictors of entering 24‐h care for people with Alzheimer's disease: results from the LASER‐AD study

G. Livingston, C. Katona, C. Cooper, 2009, International journal of geriatric psychiatry.

The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis

G. Livingston, C. Katona, 2004, International journal of geriatric psychiatry.

Pharmacological strategies in depression.

C. Katona, T. Barnes, 1985, British journal of hospital medicine.

Does a teaching programme improve general practitioners' management of depression in the elderly?

M. Orrell, C. Katona, E. Collins, 1997, Journal of affective disorders.

The attractions of medicine : the generic motivations of medical school applicants in relation to demography , personality and achievement

I. McManus, G. Livingston, C. Katona, 2016 .

Montgomery—Asberg Depression Rating Scale

C. Katona, N. Graham, R. Baldwin, 2002 .

Ethical dilemmas: should antipsychotics ever be prescribed for people with dementia?

C. Katona, C. Fox, C. Paton, 2010, British Journal of Psychiatry.

Neurotransmitters and Neurotransmitter Receptors in Depressed Suicide Victims

G. Reynolds, C. Katona, S. Cheetham, 1989 .

Screening, Detection and Management of Depression in Elderly Primary Care Attenders. II: II: Detection and Fitness for Treatment: a Case Record Study

C. Katona, P. Katona, E. Mullan, 1994 .

Racial discrimination against doctors

C. Katona, M. Robertson, 1993 .

From the periphery to the core: a Cook's tour of affective disorders

C. Katona, 1999 .

Biological aspects of affective disorders

C. Katona, R. Horton, 1991 .

Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease

I. McKeith, G. Livingston, C. Katona, 2004, Neurology.

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

J. Lindesay, T. Johnson, I. McKeith, 2012, The New England journal of medicine.

The effectiveness of collaborative care for people with memory problems in primary care: results of the CAREDEM case management modelling and feasibility study.

C. Chew‐Graham, S. Iliffe, G. Livingston, 2014, Health technology assessment.

The assessment and management of behavioural manifestations of dementia: a review and results of a controlled trial.

G. Livingston, C. Katona, A. Hinchliffe, 1997, International journal of psychiatry in clinical practice.

Acute pharmacotherapy of depression in old age: A systematic analysis focussing on numbers needed to treat

G. Livingston, C. Katona, 2000, European Neuropsychopharmacology.

C. Katona, P. Katona, E. Mullan, 1994, Family practice.

Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.

S. Reeves, G. Livingston, C. Katona, 2018, Health technology assessment.

Edinburgh Explorer Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS)

S. Reeves, G. Livingston, C. Katona, 2018 .

Skill‐based objectives for specialist training in old age psychiatry

R. Ihl, J. Copeland, C. Katona, 2003, International journal of geriatric psychiatry.

Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls

C. Katona, S. Cheetham, R. Horton, 1997, Brain Research.

The TE4D‐Cog: a new test for detecting early dementia in English‐speaking populations

G. Livingston, C. Katona, K. Johnston, 2005, International journal of geriatric psychiatry.

Depression in Old Age

C. Katona, 1994 .